This inventor holds 1 USPTO granted patent. Top assignee: Abl Bio Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ui Jung Jung: Innovator in Bispecific Antibodies
Introduction
Ui Jung Jung is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. His innovative work has the potential to advance therapeutic options for various diseases.
Latest Patents
Ui Jung Jung holds a patent for "ANTI-BCMA/ANTI-4-1BB BISPECIFIC ANTIBODIES AND USES THEREOF." This patent represents a crucial step in the development of targeted therapies that can enhance the immune response against cancer cells.
Career Highlights
He is currently employed at Abl Bio Inc., a company known for its focus on innovative biopharmaceuticals. His role at Abl Bio Inc. allows him to collaborate with other talented professionals in the field, driving forward the research and development of groundbreaking therapies.
Collaborations
Ui Jung Jung has worked alongside notable colleagues, including Kyung Jin Park and Yang Soon Lee. Their combined expertise contributes to the advancement of their projects and the overall mission of their company.
Conclusion
Ui Jung Jung's contributions to the field of bispecific antibodies exemplify the impact of innovative research in biomedicine. His work at Abl Bio Inc. and his patent highlight his commitment to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile